COVID-19 sequelae in adults aged less than 50 years: A systematic review
- PMID: 33631340
- PMCID: PMC7898978
- DOI: 10.1016/j.tmaid.2021.101995
COVID-19 sequelae in adults aged less than 50 years: A systematic review
Abstract
Background: There is emerging evidence of long-term sequelae in a considerable proportion of COVID-19 patients after recovery and the spectrum and severity of such sequelae should be systematically reviewed. This review aims to evaluate the available evidence of all intermediate and long-term COVID-19 sequelae affecting formerly healthy adults.
Methods: A systematic literature search of Embase, WHO, Scopus, Pubmed, Litcovid, bioRxiv and medRxiv was conducted with a cutoff date of the 17th September 2020 according to PRISMA guidelines and registered in PROSPERO (CRD42020208725). Search terms included "COVID-19", "coronavirus disease 2019", "SARS-CoV-2", "sequelae" and "consequence*". Publications on adult participants, with a confirmed SARS-CoV-2 infection were included. Elderly (>50 years old) and children (<18 years old) were excluded. Bias assessment was performed using a modified Newcastle-Ottawa Scale.
Results: A total of 31 papers were included. Study types included prospective and retrospective cohort studies, cross-sectional studies and case reports. Sequelae persistence since infection spanned 14 days to three months. Sequelae included persistent fatigue (39-73% of assessed persons), breathlessness (39-74%), decrease in quality of life (44-69%), impaired pulmonary function, abnormal CT findings including pulmonary fibrosis (39-83%), evidence of peri-/perimyo-/myocarditis (3-26%), changes in microstructural and functional brain integrity with persistent neurological symptoms (55%), increased incidence of psychiatric diagnoses (5.8% versus 2.5-3.4% in controls), incomplete recovery of olfactory and gustatory dysfunction (33-36% of evaluated persons).
Conclusions: A variety of organ systems are affected by COVID-19 in the intermediate and longer-term after recovery. Main sequelae include post-infectious fatigue, persistent reduced lung function and carditis. Careful follow-up post COVID 19 is indicated to assess and mitigate possible organ damage and preserve life quality.
Keywords: COVID-19; Consequences; Coronavirus; Long-term; SARS-CoV-2; Sequelae.
Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
All authors declare no conflict of interest.
Similar articles
-
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review.JAMA Netw Open. 2021 Oct 1;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568. JAMA Netw Open. 2021. PMID: 34643720 Free PMC article.
-
The prolonged health sequelae "of the COVID-19 pandemic" in sub-Saharan Africa: a systematic review and meta-analysis.Front Public Health. 2025 Jan 24;13:1415427. doi: 10.3389/fpubh.2025.1415427. eCollection 2025. Front Public Health. 2025. PMID: 39925756 Free PMC article.
-
Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.Respir Res. 2022 Sep 6;23(1):233. doi: 10.1186/s12931-022-02163-x. Respir Res. 2022. PMID: 36068582 Free PMC article.
-
Short-Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study.High Blood Press Cardiovasc Prev. 2021 Jul;28(4):373-381. doi: 10.1007/s40292-021-00454-w. Epub 2021 Apr 28. High Blood Press Cardiovasc Prev. 2021. PMID: 33909284 Free PMC article.
-
A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.J Med Virol. 2023 Jun;95(6):e28852. doi: 10.1002/jmv.28852. J Med Virol. 2023. PMID: 37288652
Cited by
-
Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions.MedComm (2020). 2022 Dec 8;3(4):e196. doi: 10.1002/mco2.196. eCollection 2022 Dec. MedComm (2020). 2022. PMID: 36514781 Free PMC article. Review.
-
Long COVID Through a Public Health Lens: An Umbrella Review.Public Health Rev. 2022 Mar 15;43:1604501. doi: 10.3389/phrs.2022.1604501. eCollection 2022. Public Health Rev. 2022. PMID: 35359614 Free PMC article. Review.
-
The Short- and Long-Term Clinical, Radiological and Functional Consequences of COVID-19.Arch Bronconeumol. 2022 Apr;58:32-38. doi: 10.1016/j.arbres.2022.03.006. Epub 2022 Apr 13. Arch Bronconeumol. 2022. PMID: 35431398 Free PMC article. Review.
-
Knowing the entire story - a focus group study on patient experiences with chronic Lyme-associated symptoms (chronic Lyme disease).BMC Prim Care. 2022 Jun 2;23(1):139. doi: 10.1186/s12875-022-01736-5. BMC Prim Care. 2022. PMID: 35655143 Free PMC article.
-
Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.Eur J Intern Med. 2021 Oct;92:55-70. doi: 10.1016/j.ejim.2021.06.009. Epub 2021 Jun 16. Eur J Intern Med. 2021. PMID: 34167876 Free PMC article.
References
-
- Veritas Health Innovation . 2020. Covidence systematic review software.
-
- World Health Organization COVID-19: vulnerable and high risk groups. 2020. https://www.who.int/westernpacific/emergencies/covid-19/information/high...
-
- Wells G., Shea B., O'Connell D., Peterson je, Welch V., Losos M., et al. 2000. The newcastle–ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis.
-
- JAMA Instructions for authors. 2020. https://jamanetwork.com/journals/jama/pages/instructions-for-authors#Sec...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous